4.8 Review

Hydrogels in Emerging Technologies for Type 1 Diabetes

Journal

CHEMICAL REVIEWS
Volume 121, Issue 18, Pages 11458-11526

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.chemrev.0c01062

Keywords

-

Funding

  1. National Science Foundation [SNM-1530522]
  2. Juvenile Diabetes Research Foundation (JDRF)
  3. Hartwell Foundation
  4. National Institutes of Health (NIH) [1R01DK105967-01A1]
  5. Novo Nordisk Company

Ask authors/readers for more resources

This review article summarizes the recent developments in the utilization of hydrogels for smart insulin delivery and insulin-producing cell therapies for type 1 diabetes management. It discusses glucose-sensitive hydrogels, pH-sensitive polymeric hydrogels, and other physiochemical signals for triggering insulin release from hydrogels. The article also explores the use of hydrogels in encapsulating insulin-secreting cells with a focus on mitigating foreign body response, providing suitable extracellular microenvironment, and enhancing mass transfer through oxygen supplementation and vascularization.
Type 1 diabetes therapies that afford tighter glycemic control in a more manageable and painless manner for patients has remained a central focus of next-generation diabetes therapies. In many of these emerging technologies, namely, self-regulated insulin delivery and cell replacement therapies, hydrogels are employed to mitigate some of the most long-standing challenges. In this Review, we summarize recent developments in the use of hydrogels for both insulin delivery and insulin-producing cell therapies for type 1 diabetes management. We first outline perspectives in glucose sensitive hydrogels for smart insulin delivery, pH sensitive polymeric hydrogels for oral insulin delivery, and other physiochemical signals used to trigger insulin release from hydrogels. We, then, investigate the use of hydrogels in the encapsulation of insulin secreting cells with a special emphasis on hydrogels designed to mitigate the foreign body response, provide a suitable extracellular microenvironment, and improve mass transfer through oxygen supplementation and vascularization. Evaluations of limitations and promising directions for future research are also considered. Continuing interdisciplinary and collaborative research efforts will be required to produce hydrogels with instructive biochemical microenvironments necessary to address the enduring challenges of emerging type 1 diabetes therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available